Policy and procedure to help prevent costly medication discrepancies
The long-term care environment is one of the most complicated and challenging clinical settings in all of medicine, placing residents who reside in a nursing home or SNF at substantial risk of adverse outcomes related to medication use. At any point in time, there are approximately 1.5 million people living in 15,000+ nursing homes across the country, with around 2.8 million having a skilled nursing facility (SNF) stay at some point throughout the year. With the complex, heavily regulated nursing home admission process and the lack of any standardized drug regimen review (DRR) process, there are many opportunities for medication errors or potentially clinically significant medication issues (PCSMI) to occur.
Effective October 1, 2018, all SNFs are required to report on the findings of their DRR process as part of the IMPACT Act. Data collection on the DRR quality measure began in 2018 for fiscal year (FY) 2020 payment determinations and subsequent years. Download a policy and procedure for drug regimen review from HCPro’s newly released book, A SNF’s Guide to Medication Reconciliation and Drug Regimen Review by Maureen McCarthy, BS, RN, RAC-MT, QCP-MT, to help ensure safe medication administration and avoid costly adverse events, such as rehospitalizations and noncompliance.